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Abstract 
Eurycomanone is a cytotoxic bioactive ingredient found in Eurycoma longifolia Jack. It 
demonstrated a general cytotoxic response against many epithelial cell types. The present study 
investigated the antiproliferative activity of eurycomanone. It showed antiproliferative effects on cancerous 
cell lines (Caov-3, HeLa, Hep G2, HM3KO and MCF-7) and relatively nontoxic on noncancerous cell lines 
(MDBK, Vero). The mode of cell death in HeLa cells induced by eurycomanone was determined by TUNEL 
assay. It detected the fluorescence in the nuclear region thereby indicating the presence of DNA 
fragmentation. The fluorescence became more intense with longer treatment durations. The apoptotic 
morphology of HeLa cells induced by eurycomanone was further confirmed by staining with nuclear 
fluorochrome Hoecsht 33258. Similar morphology was shown by HeLa cells treated with tamoxifen which 
acted as positive control. In short, eurycomanone proves to be cytotoxic towards HeLa cells by triggering 
apoptotic cell death. 
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I. Introduction 
Eurycoma longifolia Jack is one of the 
popular folks medicines of South East Asia 
including Myanmar, Indochina, Thailand, Laos, 
Cambodia and Malaysia (Kuo et al. 2004). 
E.longifolia is identified locally as Tongkat Ali in 
Malaysia, Pasakbumi or Bidara Pahit in Indonesia,  
Ian-don in Thailand and Cay ba binh translated as 
a tree which cures hundreds of deseases (Kardono 
et al, 1991). 
Several classes of compounds have been 
isolated and identified, including quassinoids 
(Morita et al, 1993; Darise et al. 1982; Ang 2002), 
canthin-6-one alkaloids ( Kardono et al. 1991; 
Mitsunaga et al. 1994), β-carboline alkaloids 
(Kardono et al 1991; Kuo et al. 2004) and 
squalene derivatives (Morita et al. 1993). 
Previous studies on the methanolic 
extract from the root of E.longifolia showed the 
antiproliferative activity towards a panel of cancer 
cell lines comprising a number of human cancer 
cell types (breast, colon, fibrosarcoma, lung, 
melanoma, KB and P-388 murine lymphocytic 
leukemia (Kardono et al. 1991). Proceed study of 
methanolic extract showed induction of apoptosis 
on human breast cancer cell lines (MCF-7) via 
decreasing of Bcl-2 proto-oncogene (Tee and 
Azimahtol, 2005). 
Apoptosis is the ability of a cell to self-
destruct by the activation of an intrinsic cellular 
suicide program when the cells are no longer 
needed or when they are seriously damaged 
(Huang et al 2003). Apoptosis is an active form of 
physiological cell death.. which is essential for 
development and for cellular and tissue 
homeostasis (Bohm and Schild, 2003). In cancer 
therapy, one approach that suppress the tumour 
growth is by activating the apoptotic machinery in 
the cell (Lowe and Lin, 2000). Moreover, the 
apoptotic process includes a mechanism that 
organized both the packaging and disposal of dead 
cells, thereby preventing inflammation of the 
surrounding tissue (Zornig et al., 2001). Evidence 
obtained during recent years is beginning to 
establish that a large of cancer chemotherapy 
agents affect tumor cell killing in  vivo and in vitro 
through launching the apoptosis cascade (Markin 
and Dive, 2001). The apoptotic cell is 
characterized by loss of cell volume, plasma-
membrane blebbing, nuclear condensation, 
chromatin aggregation and endonucleocytic 
degradation of DNA into nucleosomal fragments 
(Bohm and Schild, 2003). 
The objective of this study is to evaluate 
the antiproliferative effect of eurycomanone and 
the ability of eurycomanone to induce apoptotic 
cell death in human cervical carcinoma (HeLa) 
cells. 
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II. Materials And Methods 
Plant materials, E.longifolia roots were provided 
by Prof Dr. Azimahtol Hawariah Lope Pihie 
(National University of Malaysia). 
 
Compound extraction,  Eurycomanone extracted 
from the root of E.longifolia as previously 
described (Darise et al. 1986). Root of the plant 
were dried and ground extracted with MeOH. The 
MeOH extract was concentrated to dryness. A 
suspension of the residue in H2O was extracted 
with Et2O and then with n-BuOH saturated with 
H2O. The BuOH layer was evaporated to dryness 
and the residue was chromatographed on a Silica 
gel column, elution with EtOAc-EtOH-H2O 
(100:10:1). 
 
Cell culture conditions, Hela, CaOv-3, HepG2, 
MCF-7, HM3KO, Vero, MDBK were obtained 
from American type culture collection (ATCC) 
and maintained in DMEM that was supplemented 
with 5% fetal bovine serum and penicillin 
streptomycin. 
 
Cell proliferation assay, The antiproliferative 
effect was evaluated by obtaining the IC50 values 
for these cell lines as previously described (Lin 
and Hwang, 1991; Lee and Azimahtol, 2003). The 
cells were plated onto each well in a volume of 0.1 
ml and were allowed to attach overnight at 37 oC  
and then the seeding medium was removed and 
replaced with fresh medium containing varying 
concentration of compound. The cells were 
maintained for 3 days and the antiproliferative 
activity was determined using methylene blue 
staining. Glutaraldehyde was added to each well to 
final concentration of 2.5 % (v/v) and fixed for 15 
minutes. After washing with 0.15 M NaCl the 
fixed cells were stained with 0.1 ml of 0.05% 
methylene blue solution for 15 minutes. The 
excess dye elution was washed out and  0.33 M 
HCl (0.2 ml per well) was added. The absorbance 
read at 660 nm. 
 
TUNEL assay, DNA fragmentation, that is 
characteristic of apoptotic cells, was examined by 
Tdt-mediated dUTP nick end labelling (TUNEL) 
with the apoptotic detection kit, Florescein 
(Promega) according to the manufacturer’s 
instruction. Tamoxifen used as positive control. 
 
Nuclear staining assay. Staining with Hoechst 
33258 was performed as previously described 
(Hishikawa et al. 1999). The cells were grown in 
poly l-lysin slide, remove the old medium and 
replaced with fresh medium containing the 
compound. After incubation cells were washed 
with PBS and then fixed with 4% 
paraformaldehyde for 30 minutes. After washing, 
the cells were incubated with Hoechst 33258 
(Sigma) at a final concentration of 30 μg/ml. 
Nuclear morphology were then determined with 
Leica fluorescent microscope 
 
III. Results  
Eurycomanone significantly reduced cell 
viability (Caov-3, Hela, HepG2, HM3KO, MCF-
7) in a dose dependent manner. It is relatively 
nontoxic to normal cells (MDBK, Vero) (Fig 1). 
The IC50 of eurycomanone on cancerous cell lines 
are less than 20 μg/ml. These finding suggested 
its potential as antiproliferative agent since the 
IC50 is less than 20 μg/ml (Wall et al. 1987).
 The mode of killing that is induced by 
most anticancer agents is by apoptotic cell death. 
The antiproliferative activity shown by 
eurycomanone could possibly due to the induction 
of apoptosis. We used the TUNEL and nuclear 
staining with Hoechst 33258 to prove this 
hypothesis. 
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Fig 1. Effect of eurycomanone on cell viability 
 
Table 1. IC50 values of eurycomanone and positive 
control (tamoxifen) towards cancerous and noncancerous  
cell lines 
IC50 (μg/ml) Cell lines 
eurycomanone Tamoxifen 
Caov-3 
Hela 
HepG2 
HM3KO 
MCF-7 
3.03±0.14 
2.13±0.09 
4.02±0.12 
4.21±0.2 
3.63±0.11 
1.92±0.04 
8.13±0.19 
2.16±0.08 
 
MDBK 
Vero 
28.94±1.7 
>>> 
10±0.13 
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DNA fragmentation that is characteristic 
of apoptotic cells could be determined by Tdt-
mediated dUTP nick end labelling (TUNEL). 
DNA fragmentation generates 3’-OH DNA ends, 
which can be labeled with fluorescein-12-dUTP 
using the enzyme Terminal Deoxynucleotidyl 
Tranferase (TdT). The fluorescein-12-dUTP-
labeled DNA could be visualized by fluorescence 
microscope. Here, we labeled the eurycomanone-
treated cells to visualize the extent of DNA 
fragmentation in a time-course dependent manner 
(Fig 2).  
 
 
 
 
 
Fig 2. TUNEL labeling of HeLa cells. (a) untreated 
cells. No flurescence detected in the nucleus, as the cells 
were not apoptotic and did not exhibit DNA 
fragmentation. Eurycomanone treated cells at 24 h (b), 
48 h (c) and 72 h (d) showed fluorescence in the nuclear 
region, indicating apoptosis. The fluorescence became 
more intense with longer treatment duration. 
 
 
 
 
 
Fig 3. TUNEL labeling of tamoxifen-treated HeLa cells 
at 24 h (a), 72 h (b)  
 
 The apoptotic morphology of HeLa cells 
induced by eurycomanone was further confirmed 
by staining with nuclear fluorochrome Hoecsht 
33258.  
 
 
 
 
 
 
 
 
 
 
Fig 4. Nuclear staining of HeLa cells with Hoechst 
33258. Cells were treated with eurycomanone compare 
to untreated controls. Untreated cells (a) eurycomanone 
treated cells at 24h (b), 48h (c), 72h (c). There are no 
fluorescence detected from untreated cells, while the 
eurycomanone treated cells showed fluorescence of 
apoptotic bodies. 
IV. Discussions 
Plants are a valuable source of new 
natural products. Despite the availability of 
different approaches for the discovery of 
therapeuticals, natural products still remain one of 
the best reservoirs of new molecules  (Pezzuto 
1997). Natural plant products play an important 
role in chemotherapy, having contributed 
considerably to approximately 60 available cancer 
chemotherapeutic drugs (Kinghorn et al. 1999). 
The need to  develop more effective antitumor 
drugs has prompted investigators to explore new 
sources of pharmacologically-active compounds, 
especially from natural products. 
In cancer therapy, one approach that 
suppress the tumour growth is by activating the 
apoptotic machinery in the cell (Lowe and Lin 
2000). There are three ways for studying cell death 
that use DNA stains: dye exclusion method, 
morphological changes and profile of DNA 
content. In the study of morphological changes, 
certain dye or fluorochrome can be used to view 
the structure of viable cells and apoptotic cells. 
Morphological changes of apoptotic cells, 
chromatin condensation and formation of 
apoptotic bodies could be determined using 
Hoecsht 33258 staining. It will bind specifically to 
double stranded DNA and emit green 
fluorescence. . Hoecsht 33258 will stain both of 
healthy and apoptotic cells, but apoptotic cells will 
stain strongly distinguished from healthy that is 
homogenously. 
Untreated HeLa cells stain homogenously 
with Hoecsht 33258, no fluorescence detected 
indicating the cells are healthy while  the 
eurycomanone-treated cells showed of intense 
fluorescence indicating that cells were apoptotic.   
DNA fragmentation that is characteristic 
of apoptotic cells could be determined by Tdt-
mediated dUTP nick end labelling (TUNEL). 
DNA fragmentation generates 3’-OH DNA ends, 
which can be labeled with fluorescein-12-dUTP 
using the Terminal Deoxynucleotidyl Tranferase 
(TdT) enzyme . The fluorescein-12-dUTP-labeled 
DNA could be visualized by fluorescence 
microscope. 
The healthy, untreated HeLa cells did not 
emit yellow fluorescence indicating that none of 
the cells underwent apoptosis thus dUTP was not 
being incorporated into the DNA of the cells. Red 
stain were caused by Propidium iodide. When the 
cells fixed with 4% paraformaldehyde, it made the 
cell membrane permeable to propidium iodide. 
However, this did not indicate that cells were 
apoptotic. 
a b 
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The eurycomanone-treated HeLa cells 
showed yellow fluorescence with TUNEL assay 
indicating the DNA fragmentation. After 24 h 
treatment a few fluorescent detected and the 
fluorescense became more intense with longer 
treatment duration. The similar morphology 
showed by tamoxifen-treated HeLa cells. 
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